Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

821 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study).
Takemoto S, Fukuda M, Ogata R, Senju H, Sugasaki N, Nakatomi K, Tomono H, Suyama T, Sasaki E, Matsuo M, Akagi K, Hayashi F, Dotsu Y, Ono S, Honda N, Taniguchi H, Gyotoku H, Ikeda T, Nagashima S, Soda H, Kinoshita A, Mukae H. Takemoto S, et al. Among authors: honda n. Transl Lung Cancer Res. 2024 Oct 31;13(10):2673-2682. doi: 10.21037/tlcr-24-508. Epub 2024 Oct 24. Transl Lung Cancer Res. 2024. PMID: 39507035 Free PMC article.
Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysis.
Takemoto S, Akagi K, Ono S, Tomono H, Honda N, Suyama T, Umeyama Y, Dotsu Y, Taniguchi H, Ogawara D, Senju H, Gyotoku H, Sugasaki N, Yamaguchi H, Nakatomi K, Fukuda M, Mukae H. Takemoto S, et al. Among authors: honda n. Thorac Cancer. 2021 Sep;12(17):2300-2306. doi: 10.1111/1759-7714.14055. Epub 2021 Jul 13. Thorac Cancer. 2021. PMID: 34255933 Free PMC article.
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer.
Shimada M, Yamaguchi H, Fukuda M, Tomono H, Honda N, Dotsu Y, Taniguchi H, Gyotoku H, Senju H, Takemoto S, Ikeda T, Nakatomi K, Nakamura Y, Nagashima S, Yamazaki T, Mukae H. Shimada M, et al. Among authors: honda n. Cancer Chemother Pharmacol. 2019 Nov;84(5):1059-1064. doi: 10.1007/s00280-019-03940-0. Epub 2019 Sep 5. Cancer Chemother Pharmacol. 2019. PMID: 31486872 Clinical Trial.
Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.
Dotsu Y, Fukuda M, Honda N, Gyotoku H, Kohno Y, Suyama T, Umeyama Y, Taniguchi H, Takemoto S, Yamaguchi H, Miyazaki T, Sakamoto N, Obase Y, Ikeda H, Ashizawa K, Mukae H. Dotsu Y, et al. Among authors: honda n. Thorac Cancer. 2021 Jan;12(2):272-276. doi: 10.1111/1759-7714.13756. Epub 2020 Nov 20. Thorac Cancer. 2021. PMID: 33215864 Free PMC article.
Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case report.
Taniguchi H, Takemoto S, Ozasa M, Honda N, Suyama T, Umeyama Y, Dotsu Y, Nakao T, Tomohito K, Gyotoku H, Yamaguchi H, Miyazaki T, Sakamoto N, Obase Y, Fukuda M, Fukuoka J, Mukae H. Taniguchi H, et al. Among authors: honda n. Thorac Cancer. 2021 Apr;12(7):1126-1130. doi: 10.1111/1759-7714.13890. Epub 2021 Feb 19. Thorac Cancer. 2021. PMID: 33605089 Free PMC article.
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.
Dotsu Y, Yamaguchi H, Fukuda M, Suyama T, Honda N, Umeyama Y, Taniguchi H, Gyotoku H, Takemoto S, Tagawa R, Ogata R, Tomono H, Shimada M, Senju H, Nakatomi K, Nagashima S, Soda H, Ikeda H, Ashizawa K, Mukae H. Dotsu Y, et al. Among authors: honda n. J Clin Med. 2021 Sep 17;10(18):4221. doi: 10.3390/jcm10184221. J Clin Med. 2021. PMID: 34575334 Free PMC article.
Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy.
Takemoto S, Ozasa M, Mizuta R, Tagawa R, Ono S, Honda N, Suyama T, Umeyama Y, Dotsu Y, Gyotoku H, Yamaguchi H, Yamamoto K, Sakamoto N, Obase Y, Fukuda M, Mukae H. Takemoto S, et al. Among authors: honda n. Lung Cancer Manag. 2023 Mar 27;11(4):LMT57. doi: 10.2217/lmt-2022-0001. eCollection 2022 Dec. Lung Cancer Manag. 2023. PMID: 37284227 Free PMC article.
821 results